<SEC-DOCUMENT>0001104659-21-098517.txt : 20210802
<SEC-HEADER>0001104659-21-098517.hdr.sgml : 20210802
<ACCEPTANCE-DATETIME>20210802070026
ACCESSION NUMBER:		0001104659-21-098517
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210802
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210802
DATE AS OF CHANGE:		20210802

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMICUS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001178879
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				200422823
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33497
		FILM NUMBER:		211134711

	BUSINESS ADDRESS:	
		STREET 1:		3675 MARKET STREET
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104
		BUSINESS PHONE:		(215) 921-7600

	MAIL ADDRESS:	
		STREET 1:		3675 MARKET STREET
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMICUS THERAPEUTICS INC
		DATE OF NAME CHANGE:	20020729
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2123815d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:fold="http://amicustherapeutics.com/20210802">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_US%2DGAAP%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_fold_amicustherapeutics.com_20210802 -->
<!-- Field: Set; Name: xdx; ID: xdx_040_20210802_20210802 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001178879 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:EntityCentralIndexKey">0001178879</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-08-02to2021-08-02" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fold-20210802.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-08-02to2021-08-02">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178879</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-02</xbrli:startDate>
        <xbrli:endDate>2021-08-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt"><b>UNITED
STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt"><b>WASHINGTON,
D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt"><b>FORM
<span id="xdx_905_edei--DocumentType_c20210802__20210802_zQekNLiN9fo7"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt"><b>CURRENT
REPORT PURSUANT TO</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt"><b>SECTION
13 OR 15(d) OF THE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt"><b>SECURITIES
EXCHANGE ACT OF 1934</b></p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt">Date
of Report (Date of earliest event reported): <b><span id="xdx_90D_edei--DocumentPeriodEndDate_c20210802__20210802_zlfGZYzJDERi"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">August 2, 2021</ix:nonNumeric></span></b></p>

<p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>


<p style="font: 18pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt"><b><span id="xdx_907_edei--EntityRegistrantName_c20210802__20210802_zVBahcg0Fex"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:EntityRegistrantName">AMICUS THERAPEUTICS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt">(Exact
Name of Registrant as Specified in Its Charter)</p>

<p style="font-size: 10pt; text-align: center; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%; border-collapse: collapse; text-align: left">
<tr style="vertical-align: bottom">
    <td style="padding: 2px; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20210802__20210802_z0rYghXGJx9b"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="padding: 2px; text-align: left; width: 1%">&#160;</td>
    <td style="padding: 2px; text-align: center; width: 34%"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--EntityFileNumber_c20210802__20210802_zONRQTwaZO3h"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:EntityFileNumber">001-33497</ix:nonNumeric></span></span></td>
    <td style="padding: 2px; text-align: left; width: 1%">&#160;</td>
    <td style="padding: 2px; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;<span id="xdx_907_edei--EntityTaxIdentificationNumber_c20210802__20210802_zBp7ixED48Rg"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:EntityTaxIdentificationNumber">71-0869350</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 2px; text-align: center"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(State or Other Jurisdiction</b></p>
        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>of Incorporation)</b></p></td>
    <td style="padding: 2px; text-align: center"><b>&#160;</b></td>
    <td style="padding: 2px; text-align: center"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(Commission</b></p>
        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>File Number)</b></p></td>
    <td style="padding: 2px; text-align: center"><b>&#160;</b></td>
    <td style="padding: 2px; text-align: center"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(I.R.S. Employer</b></p>
        <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Identification No.)</b></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 192px; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; text-indent: 192px; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_90E_edei--EntityAddressAddressLine1_c20210802__20210802_znEaAHXFFezc"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:EntityAddressAddressLine1">3675 Market Street</ix:nonNumeric></span>,
<span id="xdx_909_edei--EntityAddressCityOrTown_c20210802__20210802_zoMbXuNFLCod"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:EntityAddressCityOrTown">Philadelphia</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20210802__20210802_zUcDmUIHCCab"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:EntityAddressStateOrProvince">PA</ix:nonNumeric></span> <span id="xdx_908_edei--EntityAddressPostalZipCode_c20210802__20210802_za6wOaYY05ug"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:EntityAddressPostalZipCode">19104</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(Address of Principal
Executive Offices, and Zip Code)</b></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span id="xdx_906_edei--CityAreaCode_c20210802__20210802_zRpERwALZIZg"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:CityAreaCode">215</ix:nonNumeric></span>-<span id="xdx_908_edei--LocalPhoneNumber_c20210802__20210802_z1390908DpPa"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:LocalPhoneNumber">921-7600</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Registrant&#8217;s
Telephone Number, Including Area Code</b></p>

<p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Former Name or Former
Address, if Changed Since Last Report.)</p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in; text-align: justify; text-indent: -2px; margin-top: 0pt; margin-bottom: 0pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:</p>

<p style="font-size: 10pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font-family: Wingdings"><span id="xdx_904_edei--WrittenCommunications_c20210802__20210802_z3f9dPMsyog2"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font-family: Wingdings"><span id="xdx_90F_edei--SolicitingMaterial_c20210802__20210802_zyZUmk5r4v08"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font-family: Wingdings"><span id="xdx_901_edei--PreCommencementTenderOffer_c20210802__20210802_zYn4kOP0cRR7"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
<tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
</table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: top">
    <td style="width: 0.2in"><span style="font-family: Wingdings"><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20210802__20210802_zvZdY5X2OSva"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Securities registered pursuant
to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto; width: 100%; border-collapse: collapse; text-align: left">
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1px solid; border-left: Black 1px solid; padding: 2px; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif">Title of each class</span></td>
    <td style="border-top: Black 1px solid; border-left: Black 1px solid; padding: 2px; text-align: center; width: 28%"><span style="font: 10pt Times New Roman, Times, Serif">Trading Symbol(s)</span></td>
    <td style="border-top: Black 1px solid; border-right: Black 1px solid; border-left: Black 1px solid; padding: 2px; text-align: center; width: 40%"><span style="font: 10pt Times New Roman, Times, Serif">Name of each exchange on which registered</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border: #000000 1px solid; padding: 2px; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--Security12bTitle_c20210802__20210802_zjwNlvcGmIUf"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:Security12bTitle">Common Stock Par Value $0.01</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1px solid; border-bottom: Black 1px solid; padding: 2px; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--TradingSymbol_c20210802__20210802_zfaf2nRBv1of"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" name="dei:TradingSymbol">FOLD</ix:nonNumeric></span></span></td>
    <td style="border: #000000 1px solid; padding: 2px; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--SecurityExchangeName_c20210802__20210802_zHfUj7FfqTLe"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2). Emerging growth company <span style="font-family: Wingdings"><span id="xdx_90B_edei--EntityEmergingGrowthCompany_c20210802__20210802_zsvUBwGhdghc"><ix:nonNumeric contextRef="From2021-08-02to2021-08-02" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font-size: 10pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>

<p style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0; margin-bottom: 0; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.25pt"><b>Item 8.01 &#8211; Other Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">On August 2, 2021, Amicus Therapeutics, Inc. issued
a press release announcing the European Commission has approved Galafold&#174; (migalastat) for use in adolescents aged 12 to &lt;16 years
weighing &#8805; 45 kg with a confirmed diagnosis of Fabry disease and who have an amenable mutation. A copy of this press release is
attached hereto as Exhibit 99.1 and incorporated herein by reference.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.25pt"><b>Item 9.01 Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 29.25pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.25pt; text-indent: 2.25pt"><b>(d) Exhibits:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 29.25pt; text-indent: 2.25pt"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 5%">&#160;</td>
    <td style="width: 15%; padding-bottom: 1.5pt; text-align: center"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="border-top: black 1pt solid; padding-top: 2.75pt; padding-bottom: 1.5pt; text-align: center"><a href="tm2123815d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">99.1</span></a></td>
    <td>&#160;</td>
    <td style="border-top: black 1pt solid; padding-top: 2.75pt; padding-bottom: 1.5pt"><a href="tm2123815d1_ex99-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Press Release dated August 2, 2021</span></a></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-top: 3.75pt; padding-bottom: 1.5pt; text-align: center"><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="padding-top: 3.75pt; padding-bottom: 1.5pt"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">Signature Page</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27.35pt; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 27.35pt; text-indent: 0.25in">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt">AMICUS THERAPEUTICS, INC.</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 50%"><span style="font-size: 10pt">Date: August 2, 2021</span></td>
    <td style="width: 5%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; width: 45%"><span style="font-size: 10pt">/s/ Ellen S. Rosenberg</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Name:</span></td>
    <td> <span style="font-size: 10pt">Ellen S. Rosenberg</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title: </span></td>
    <td><span style="font-size: 10pt">Chief Legal Officer and Corporate Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjV0KwjAQhE/QOyx5Fk0KovbRokWsIkXE19iuEmyzZRP/juQtjS3isrAsM9+MEAOR0dLUyHCcFznssWlr7REKPCOjLTE40tU6gXALvBjnWVvfvT8wpcBgYMZDeSqD0FnvxmGVgJyO5GSkZiBniVKw24joq6dkz6ZC642uQdsKdkwtG/SaX33CXj/JUvPqqg7IzpBNQA1lL78hliqGLd31g/jqIM9TEQ26iUTGdGu/NTfnqYFFjU3ocj363+gDPyxJhA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2123815d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

                           <P STYLE="margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><IMG SRC="tm2123815d1_ex99-1mg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Amicus Therapeutics Announces European Commission
Approval of Galafold<SUP>&reg;</SUP> (migalastat) for Adolescents with Fabry Disease</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><I>Galafold</I></FONT><SUP>&reg;</SUP>
<FONT STYLE="font-size: 10pt"><I>is the First and Only Oral Therapy Approved in the EU for the Long-term Treatment of Adolescents with
Fabry Disease Aged 12 years and older with an Amenable Mutation</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PHILADELPHIA, PA, Aug. 2, 2021</B> &#8211;
<U>Amicus Therapeutics</U> (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering
novel medicines for rare diseases, today announced the European Commission has approved Galafold<SUP>&reg;</SUP> (migalastat) for use
in adolescents aged 12 to &lt;16 years weighing &#8805; 45 kg with a confirmed diagnosis of Fabry disease and who have an amenable mutation.
Galafold is already approved in multiple geographies around the world, including the U.S., EU, and Japan, for adults who have an amenable&nbsp;variant,
or mutation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Bradley Campbell, President and Chief Operating
Officer of Amicus Therapeutics, Inc., stated, &#8220;This approval of Galafold is a transformative moment for the Fabry community in the
EU, as it gives those patients as young as 12 years of age with an amenable mutation a new treatment option for the first time in more
than 15 years. We are grateful to this wonderful and passionate community, particularly the patients, physicians, and families who have
made this research possible through their participation in the clinical trials, as well as to the regulators and our dedicated Amicus
team. This achievement highlights our company&#8217;s mission, which is focused on transforming the lives of people living with rare diseases.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8220;This expanded approval is a significant
step forward for the Fabry community as we work to elevate awareness of this rare disease in adolescents and ensure patients, both paediatric
and adult, have meaningful treatment options available. An oral disease modifying therapy will be an exciting option for young people
with Fabry Disease,&#8221; said Uma Ramaswami, MD, Lysosomal Storage Disease Unit, Royal Free London NHS Foundation Trust. &#8220;Fabry
disease can have significant impacts on families, and we are pleased there is now an approved oral medicine for the younger members of
our community and the families who care for them in the EU.&#8221;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The extension of the indication was supported
by 1-month interim safety and <FONT STYLE="color: #202124; background-color: white">pharmacokinetics&nbsp;</FONT>data from Study AT1001-020
which was a 2-stage, open-label, multicenter study to evaluate the safety, <FONT STYLE="color: #202124; background-color: white">pharmacokinetics</FONT>,
<FONT STYLE="color: #202124; background-color: white">pharmacodynamics</FONT>, and efficacy of migalastat treatment in pediatric subjects
aged 12 to &lt;18 years and weighing &#8805; 45 kg with Fabry disease and with amenable mutations to the gene encoding &#945;-galactosidase
A (<I>GLA</I>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amicus will work closely with all relevant government
authorities to secure access for eligible patients as quickly as possible. Galafold is not approved for adolescents outside of Europe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B><U>About Fabry Disease</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="background-color: white">Fabry
disease<FONT STYLE="color: #212529">&nbsp;is an inherited lysosomal disorder caused by deficiency of an enzyme called alpha-galactosidase
A (alpha-Gal A), which is the result of mutations in the GLA gene. The primary biological function of alpha-Gal A is to degrade specific
lipids in lysosomes, including globotriaosylceramide (referred to here as GL-3 and also known as Gb3). Lipids that can be degraded by
the action of alpha-Gal A are called &quot;substrates&quot; of the enzyme. Reduced or absent levels of alpha-Gal A activity lead to the
accumulation of GL-3 in the affected tissues, including the central nervous system, heart, kidneys, and skin. Progressive accumulation
of GL-3 is believed to lead to the morbidity and mortality of Fabry disease, including pain, kidney failure, heart disease, and stroke.
The symptoms can be severe, differ from patient to patient, and begin at an early age. All Fabry disease is progressive and may lead to
irreversible organ damage regardless of the time of symptom onset.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B><U>About Galafold</U>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B><BR>
Galafold<SUP>&reg;</SUP>&nbsp;(migalastat) 123 mg capsules is an oral pharmacological chaperone of alpha-Galactosidase A (alpha-Gal A)
for the treatment of Fabry disease in adults who have amenable&nbsp;galactosidase alpha gene (<I>GLA)</I>&nbsp;variants. In these patients,
Galafold works by stabilizing the body&#8217;s own dysfunctional enzyme so that it can clear the accumulation of disease substrate. Globally,
Amicus Therapeutics estimates that approximately 35 to 50 percent of Fabry patients may have amenable&nbsp;<I>GLA</I>&nbsp;variants,
though amenability rates within this range vary by geography. Galafold is approved in over 40 countries around the world, including the
U.S., EU, U.K., Japan and others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><IMG SRC="tm2123815d1_ex99-1mg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>U.S. INDICATIONS AND USAGE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white"><B>&nbsp;</B><BR>
Galafold is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene
(<I>GLA</I>) variant based on&nbsp;<I>in&nbsp;vitro</I>&nbsp;assay data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">This indication is approved
under accelerated approval based on reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued
approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>U.S. IMPORTANT SAFETY
INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>ADVERSE REACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B></B>The most
common adverse reactions reported with Galafold (&#8805;10%) were headache, nasopharyngitis, urinary tract infection, nausea and pyrexia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>USE IN SPECIFIC POPULATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B></B>There is
insufficient clinical data on Galafold use in pregnant women to inform a drug-associated risk for major birth defects and miscarriage.
Advise women of the potential risk to a fetus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">It is not known if Galafold
is present in human milk. Therefore, the developmental and health benefits of breastfeeding should be considered along with the mother&#8217;s
clinical need for Galafold and any potential adverse effects on the breastfed child from Galafold or from the underlying maternal condition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Galafold is not recommended
for use in patients with severe renal impairment or end-stage renal disease requiring dialysis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">The safety and effectiveness
of Galafold have not been established in pediatric patients.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">To report Suspected Adverse
Reactions, contact Amicus Therapeutics at 1-877-4AMICUS or FDA at&nbsp;1-800-FDA-1088 or&nbsp;www.fda.gov/medwatch<FONT STYLE="color: #333333">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">For additional information
about Galafold, including the full U.S. Prescribing Information, please visit&nbsp;https://www.amicusrx.com/pi/Galafold.pdf<FONT STYLE="color: #333333">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>EU Important Safety Information</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Treatment with Galafold should be initiated and
supervised by specialists experienced in the diagnosis and treatment of Fabry disease. Galafold is not recommended for use in patients
with a nonamenable mutation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify">Galafold is not intended for concomitant use with enzyme replacement
therapy.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify">Galafold is not recommended for use in patients with Fabry disease
who have severe renal impairment (&lt;30 mL/min/1.73 m2). The safety and efficacy of Galafold in children less than 12 years of age have
not yet been established. No data are available.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify">No dosage adjustments are required in patients with hepatic
impairment or in the elderly population.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify">There is very limited experience with the use of this medicine
in pregnant women. If you are pregnant, think you may be pregnant, or are planning to have a baby, do not take this medicine until you
have checked with your doctor, pharmacist, or nurse.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify">While taking Galafold, effective birth control should be used.
It is not known whether Galafold is excreted in human milk.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify">Contraindications to Galafold include hypersensitivity to the
active substance or to any of the excipients listed in the PRESCRIBING INFORMATION.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify">Galafold 123 mg capsules are not for children (&ge;12 years)
weighing less than 45 kg.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify">It is advised to periodically monitor renal function, echocardiographic
parameters and biochemical markers (every 6 months) in patients initiated on Galafold or switched to Galafold.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify">OVERDOSE: General medical care is recommended in the case of
Galafold overdose.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&bull;</TD><TD STYLE="text-align: justify">The most common adverse reaction reported was headache, which
was experienced by approximately 10% of patients who received Galafold. For a complete list of adverse reactions, please review the SUMMARY
OF PRODUCT CHARACTERISTICS. </TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD>&nbsp;</TD><TD STYLE="text-align: left">&bull;</TD><TD STYLE="text-align: justify">Call your doctor for medical advice about side effects.</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For further important safety information for Galafold,
including posology and method of administration, special warnings, drug interactions and adverse drug reactions, please see the European
SmPC for Galafold available from the EMA website at www.ema.europa.eu.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00B0F0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00B0F0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00B0F0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00B0F0"><IMG SRC="tm2123815d1_ex99-1mg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #00B0F0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>About Amicus Therapeutics </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Amicus Therapeutics (Nasdaq: FOLD) is a global,
patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living
with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline
of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company&#8217;s
website at www.amicusrx.com, and follow on Twitter and LinkedIn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release contains &quot;forward-looking
statements&quot; within the meaning of the Private Securities Litigation Reform Act of 1995 relating to approval and commercialization
plans for Galafold. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans
will be achieved. Any or all of the forward-looking statements in this press release may turn out to be wrong and can be affected by inaccurate
assumptions we might make or by known or unknown risks and uncertainties. For example, actual results may differ materially from those
set forth in this release due to the risks and uncertainties inherent in our business, including, without limitation: the potential that
we may not be successful in commercializing Galafold in the United States, the potential that public and commercial payors will not reimburse
Galafold, the potential that we may not be able to manufacture or supply sufficient commercial products; and the potential that we will
need additional funding to complete all of our commercialization and manufacturing activities. In addition, all forward-looking statements
are subject to other risks detailed in our Annual Report on Form 10-K for the year ended December 31, 2020 and Quarterly Report 10-Q for
the quarter ended March 31, 2021, You are cautioned not to place undue reliance on these forward-looking statements, which speak only
as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and we undertake no
obligation to revise or update this news release to reflect events or circumstances after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B><U>CONTACTS:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Investors:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Andrew Faughnan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Executive Director, Investor
Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">afaughnan@amicusrx.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(609) 662-3809</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Media:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Diana Moore</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Head of Global Corporate
Communications</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">dmoore@amicusrx.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(609) 662-5079</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">FOLD&#8211;G</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>fold-20210802.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWamCCbOdzZR+OYkxtmB1bel6LyckBCMXVSIIq7t24asN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:fold="http://amicustherapeutics.com/20210802" elementFormDefault="qualified" targetNamespace="http://amicustherapeutics.com/20210802">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://amicustherapeutics.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="fold-20210802_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fold-20210802_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>fold-20210802_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>fold-20210802_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.9a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://amicustherapeutics.com/role/Cover" xlink:href="fold-20210802.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://amicustherapeutics.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2123815d1_ex99-1mg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2123815d1_ex99-1mg001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  O (T# 2(  A$! Q$!_\0
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M6X6\F++<Q;?+A)+2*@!;*U^6_P"VM^S7^TQ\8?VG_P!F+XB_"/\ :/T_X6>
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M.ECL)2K9+A(4>'8)RC['$QMG#S"%ZDG''/.XQRY5Z?+!9>Y4'3]O^_7YF?\
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MASX9U+3KQ;"2PTV74[9YKN6",":WC)6.5BQ1":^ZR'B3A#A;%</99A<]RV.
MP7C.\[A6C'FK5.&ED+QJP==SHN$LO^L+V=3#QIJ4N5N,FYQ9\EGF1<4\087-
M<TS/)\PK8]^#_P#8ZH<[6'EGW]O?4'BU3YG-YC]63J>U]INY2=/V?NK\9?\
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M>C>";;X0:;\<O''P$GT.\U">P\92+X%MM0TVY\?VMUJ,]K:7\\WC#2[O18O
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EPY4G&RNI)N^JZ<MEW;5W:]CU\AP./P=&5/'U/:.^EF[>75G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tm2123815d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fold-20210802.xsd" xlink:type="simple"/>
    <context id="From2021-08-02to2021-08-02">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178879</identifier>
        </entity>
        <period>
            <startDate>2021-08-02</startDate>
            <endDate>2021-08-02</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-08-02to2021-08-02">0001178879</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-08-02to2021-08-02">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-08-02to2021-08-02">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-08-02to2021-08-02">2021-08-02</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-08-02to2021-08-02">AMICUS THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-08-02to2021-08-02">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-08-02to2021-08-02">001-33497</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-08-02to2021-08-02">71-0869350</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-08-02to2021-08-02">3675 Market Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-08-02to2021-08-02">Philadelphia</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-08-02to2021-08-02">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-08-02to2021-08-02">19104</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-08-02to2021-08-02">215</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-08-02to2021-08-02">921-7600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-08-02to2021-08-02">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-08-02to2021-08-02">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-08-02to2021-08-02">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-08-02to2021-08-02">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-08-02to2021-08-02">Common Stock Par Value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-08-02to2021-08-02">FOLD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-08-02to2021-08-02">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-08-02to2021-08-02">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139676653148088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 02, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  02,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMICUS THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001178879<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">71-0869350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3675 Market Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Philadelphia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">19104<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">921-7600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock Par Value $0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FOLD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M;%!+ 0(4 Q0    (  DX E-H77*4[@   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  DX E.97)PC$ 8  )PG
M   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ "3@"4RG5H9LV!   *Q   !@              ("!#0@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  DX E.?H!OPL0(  .(,
M   -              "  7D,  !X;"]S='EL97,N>&UL4$L! A0#%     @
M"3@"4Y>*NQS     $P(   L              ( !50\  %]R96QS+RYR96QS
M4$L! A0#%     @ "3@"4ZK$(A8S 0  (@(   \              ( !/A
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  DX E,D'INBK0   /@!   :
M              "  9X1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    (  DX E-ED'F2&0$  ,\#   3              "  8,2  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  ,T3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2123815d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://amicustherapeutics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2123815d1_8k.htm">tm2123815d1_8k.htm</File>
    <File>fold-20210802.xsd</File>
    <File>fold-20210802_lab.xml</File>
    <File>fold-20210802_pre.xml</File>
    <File>tm2123815d1_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2123815d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2123815d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fold-20210802_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fold-20210802_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "fold-20210802.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fold",
   "nsuri": "http://amicustherapeutics.com/20210802",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2123815d1_8k.htm",
      "contextRef": "From2021-08-02to2021-08-02",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://amicustherapeutics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2123815d1_8k.htm",
      "contextRef": "From2021-08-02to2021-08-02",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://amicustherapeutics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001104659-21-098517-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-21-098517-xbrl.zip
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MF-%4FZEMDP12PVCF6L<*@].@;EN/0PS"G$D5?X8Q2;E-[RXEG(T91!XR1$W
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MY@OH@L"EQYSQ)+B4MW#QVB==TCS)]_)UO9OM9D6XI8BFQ!4AD#E%AIX>!!&
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M./\H50/WWC\8)?/3XK1-VIN;4A,>*FUCO0U-J?8/QAW+<IS^.WGNO&2WB[U
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M;#&H#9L;BB!( 6U!@^;FEQ-\K@RX7:5)=)4R#-^5:6D<KP=HVM.6 CP( N+
M= 4M %@(4:'T2,%G3)_X]CF/]G><183(-[JRNOWJNVLW,-HM.6\J4INI0:$!
MT?86OP"'ARQ0(X\/C3[,_RU ^>*Z7*N.14^+1RQ.X^TVSV3/*NS!]]$[@QP_
MH!A0 .TQ14=$0  .L D]LB@B41'Z 97!J!'M]1HN.ZQT2.+/^WOR0+B< ;$D
MN_RS.-Q3QU7(@%C75WB#BZ-?\/4&!H'B6]U"EX,9:F: 5O)-M"H+]+O,!!6Y
MV+X-W]QU+;;$;K5+_%KAC(@]_P502P,$%     @ "3@"4R_P#I5@!P  2ED
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MJ\7AT[Z7VA#^'UO6W7-6VT/)(R:](:$X#RV+/N >?O@6.!V90"FCY+F5<G#
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M,50$ZZ)]HNO6'G!O!2Z^<;_<FV_MD?\!4$L#!!0    (  DX E-5:67%%1(
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M S+J<]4PMUKWY%#FQ<YN0>SPX(4"\DE0G4]S] E2L<-K<R*3<5_[PO&T";*
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MWA%G-G)\*XYEFGW558;MCZ\R/&[*_]$U9I/^12FN&?._1/7_4$L! A0#%
M  @ "3@"4S:\$])) P  KPP  !$              ( !     &9O;&0M,C R
M,3 X,#(N>'-D4$L! A0#%     @ "3@"4\* #'( "P  X8<  !4
M     ( !> ,  &9O;&0M,C R,3 X,#)?;&%B+GAM;%!+ 0(4 Q0    (  DX
M E,O\ Z58 <  $I9   5              "  :L.  !F;VQD+3(P,C$P.# R
M7W!R92YX;6Q02P$"% ,4    "  ). )356EEQ142   P8P  $@
M    @ $^%@  =&TR,3(S.#$U9#%?.&LN:'1M4$L! A0#%     @ "3@"4\(Q
M3&8/%P  D&H  !8              ( !@R@  '1M,C$R,S@Q-60Q7V5X.3DM
;,2YH=&U02P4&      4 !0!) 0  QC\

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
